Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT07073898
Official study title

UG3 Pilot Clinical Trial

Study summary

LungSMART Utah utilizes a Population Health Management (PHM) approach that addresses key barriers to Lung Cancer Screening (LCS) implementation by deploying a centralized Hub infrastructure for eligibility assessment, individualized risk assessment and Shared Decision Making (SDM), LCS referral, and screening completion assistance, thereby increasing LCS reach at scale among Community Health Centers (CHCs) patients across the state of Utah.

Ask AI to explain this study
Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedRepeated Text Messages (TM+) and Conversational Agent (CA)

Plus 3 other study approaches.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 14, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Utah

Study sponsor

01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
University of Utah
Interventions being studied
Other: Repeated Text Messages (TM+); Other: Conversational Agent (CA); Other: Educational Video; Other: Proactive Patient Navigation (PPN); Other: Reactive Patient Navigation (RPN)
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Is currently a patient at Mountainlands CHCs
  • Speak English or Spanish
  • Current or former male or female smokers
  • Age 50-80
  • Have a phone that can receive text messages
  • Electronic health records indicate they have not opted out of receiving text contact from the clinic
Reasons someone may not be able to joinExclusion criteria

Persons with lung cancer or previous SDM

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Huntsman Cancer Institute/ University of UtahSalt Lake City, Utah

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 14, 2026. Always confirm current availability with the study team.

View original record ↗